The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

 
Web www.patentalert.com

< Modulators of ATP-binding cassette transporters

> Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors

> Ubiquitin ligase inhibitors and methods related thereto
~ 00576